A MAJOR WEALTH GENERATION OPPORTUNITY IS AHEAD IN ALZHEIMER’S DRUGS

For the first time in two decades, the FDA has approved a new Alzheimer's drug.  The drug is  from Biogen (BIIB).  There is a great unmet need for Alzheimer's treatment.   Can you imagine investors getting ...
Read more »

A NEW PROMISING DRUG FOR ALZHEIMER’S — OPPORTUNITY FOR INVESTORS

Alzheimer's Alzheimer's is a terrible disease.  A new patient is diagnosed with Alzheimer's in the United States every 65 seconds.  More than 5.8 million Americans are living with Alzheimer's.  For those who are over 65, one ...
Read more »

You are receiving less than 2% of the content from our paid services ...TO RECEIVE REMAINING 98%, TAKE A FREE TRIAL TO PAID SERVICES.

Please click here to take advantage of a FREE 30 day trial.

Check out our enviable performance in both bull and bear markets.

A MENACING PATTERN HAS REVEALED ITSELF IN THE STOCK MARKET $FB $AAPL $AMZN $NVDA $AMD $TSLA $INTC $EXPE $XOM $AMGN $AMAT $WDC $EA

Prudent investors ought to pay attention to a menacing pattern developing in the stock market. Please click here for an annotated chart. The chart is of the Nasdaq 100 ETF QQQ,  A similar pattern can be seen ...
Read more »

ACORDA THERAPEUTICS (ACOR) AND BIOGEN (BIIB) RUMOR MONGERS OUT IN FORCE

Acorda Therapeutics (ACOR)  rumor spreaders are out in force. They are misleading the uninformed investors about a statement Biogen  (BIIB) just made at a conference. We have taken partial profits on Acorda  at $30.20. Our highest ...
Read more »

You are receiving less than 2% of the content from our paid services ...TO RECEIVE REMAINING 98%, TAKE A FREE TRIAL TO PAID SERVICES.

Please click here to take advantage of a FREE 30 day trial.

Check out our enviable performance in both bull and bear markets.

Follow

Get every new post delivered to your Inbox

Join other followers